References
- Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017;71(1):96–108. doi:https://doi.org/10.1016/j.eururo.2016.06.010
- Singh S, Singh PP, Roberts LR, Sanchez W. Chemopreventive strategies in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2014;11(1):45–54. doi:https://doi.org/10.1038/nrgastro.2013.143
- Gallagher EJ, Neel BA, Antoniou IM, Yakar S, LeRoith D. The increased risk of cancer in obesity and type 2 diabetes: potential mechanisms. In: Poretsky L, editor. Principles of diabetes mellitus. Cham (Switzerland): Springer International Publishing; 2017. p. 731–753.
- Center MM, Jemal A. International trends in liver cancer incidence rates. Cancer Epidemiol Biomark Prev. 2011;20(11):2362–2368. doi:https://doi.org/10.1158/1055-9965.EPI-11-0643
- Cragg GM, Newman DJ. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta. 2013;1830(6):3670–3695. doi:https://doi.org/10.1016/j.bbagen.2013.02.008
- Parasuraman S, Thing GS, Dhanaraj SA. Polyherbal formulation: concept of ayurveda. Pharmacog Rev. 2014;8(16):73–80. doi:https://doi.org/10.4103/0973-7847.134229
- Atanasov AG, Waltenberger B, Pferschy-Wenzig E-M, Linder T, Wawrosch C, Uhrin P, Temml V, Wang L, Schwaiger S, Heiss EH, et al. Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol Adv. 2015;33(8):1582–1614. doi:https://doi.org/10.1016/j.biotechadv.2015.08.001
- Scannell JW, Blanckley A, Boldon H, Warrington B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov. 2012;11(3):191–200. doi:https://doi.org/10.1038/nrd3681
- Saha S, Sadhukhan P, Mahalanobish S, Dutta S, Sil PC. Ameliorative role of genistein against age-dependent chronic arsenic toxicity in murine brains via the regulation of oxidative stress and inflammatory signaling cascades. J Nutritional Biochem. 2018;55:26–40. doi:https://doi.org/10.1016/j.jnutbio.2017.11.010
- Nobili S, Lippi D, Witort E, Donnini M, Bausi L, Mini E, Capaccioli S. Natural compounds for cancer treatment and prevention. Pharmacol Res. 2009;59(6):365–378. doi:https://doi.org/10.1016/j.phrs.2009.01.017
- Topalian SL, Drake CG, Pardoll DM. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell. 2015;27(4):450–461. doi:https://doi.org/10.1016/j.ccell.2015.03.001
- Gotwals P, Cameron S, Cipolletta D, Cremasco V, Crystal A, Hewes B, Mueller B, Quaratino S, Sabatos-Peyton C, Petruzzelli L, et al. Prospects for combining targeted and conventional cancer therapy with immunotherapy. Nat Rev Cancer. 2017;17(5):286–301. doi:https://doi.org/10.1038/nrc.2017.17
- Hong M, Li S, Tan HY, Wang N, Tsao S-W, Feng Y. Current status of herbal medicines in chronic liver disease therapy: the biological effects, molecular targets and future prospects. Int J Mol Sci. 2015;16(12):28705–28745. doi:https://doi.org/10.3390/ijms161226126
- Turati F, Rossi M, Pelucchi C, Levi F, La Vecchia C. Fruit and vegetables and cancer risk: a review of southern European studies. Br J Nutr. 2015;113(S2):S102–S110. doi:https://doi.org/10.1017/S0007114515000148
- Ren M, Ye L, Hao X, Ren Z, Ren S, Xu K, Li J. Polysaccharides from Tricholoma matsutake and Lentinus edodes enhance 5-fluorouracil-mediated H22 cell growth inhibition. J Tradit Chin Med. 2014;34(3):309–316. doi:https://doi.org/10.1016/S0254-6272(14)60095-9
- Jo JY, De Mejia EG, Lila MA. Cytotoxicity of bioactive polymeric fractions from grape cell culture on human hepatocellular carcinoma, murine leukemia and non-cancerous PK15 kidney cells. Food Chem Toxicol. 2006;44(10):1758–1767. doi:https://doi.org/10.1016/j.fct.2006.05.014
- Chatterjee R, Mitra A. An overview of effective therapies and recent advances in biomarkers for chronic liver diseases and associated liver cancer. Int Immunopharmacol. 2015;24(2):335–345. doi:https://doi.org/10.1016/j.intimp.2014.12.024
- Petrovic V, Nepal A, Olaisen C, Bachke S, Hira J, Søgaard C, Røst L, Misund K, Andreassen T, Melø T, et al. Anti-cancer potential of homemade fresh garlic extract is related to increased endoplasmic reticulum stress. Nutrients. 2018;10(4):450. doi:https://doi.org/10.3390/nu10040450
- Khazaei S, Esa NM, Ramachandran V, Hamid RA, Pandurangan AK, Etemad A, Ismail P. In vitro antiproliferative and apoptosis inducing effect of Allium atroviolaceum bulb extract on breast, cervical, and liver cancer cells. Front Pharmacol. 2017;8:5. doi:https://doi.org/10.3389/fphar.2017.00005
- Sengupta A, Ghosh S, Bhattacharjee S. Allium vegetables in cancer prevention: an overview. Asian Pac J Cancer Prev. 2004;5(3):237–245.
- Ng KTP, Guo DY, Cheng Q, Geng W, Ling CC, Li CX, Liu XB, Ma YY, Lo CM, Poon RTP, et al. A garlic derivative, S-allylcysteine (SAC), suppresses proliferation and metastasis of hepatocellular carcinoma. PLoS One. 2012;7(2):e31655. doi:https://doi.org/10.1371/journal.pone.0031655
- Chu YL, Ho CT, Chung JG, Rajasekaran R, Sheen LY. Allicin induces p53-mediated autophagy in Hep G2 human liver cancer cells. J Agric Food Chem. 2012;60(34):8363–8371. doi:https://doi.org/10.1021/jf301298y
- Bagul M, Kakumanu S, Wilson TA. Crude garlic extract inhibits cell proliferation and induces cell cycle arrest and apoptosis of cancer cells in vitro. J Med Food. 2015;18(7):731–737. doi:https://doi.org/10.1089/jmf.2014.0064
- Akhtar T, Sheikh N. Chemopreventive prospective of dietary spices against hepatocellular carcinoma. Curr Sci. 2016;110(4):579–583. doi:https://doi.org/10.18520/cs/v110/i4/579-583
- Bai Z-T, Wu Z-R, Xi L-L, Li X, Chen P, Wang F-Q, Meng W-B, Zhou W-C, Wu X-A, Yao X-J, et al. Inhibition of invasion by N-trans-feruloyloctopamine via AKT, p38MAPK and EMT related signals in hepatocellular carcinoma cells. Bioorg Med Chem Lett. 2017;27(4):989–993. doi:https://doi.org/10.1016/j.bmcl.2016.12.073
- Chang RC, So KF. Use of anti-aging herbal medicine, Lycium barbarum, against aging-associated diseases. What do we know so far? Cell Mol Neurobiol. 2008;28(5):643–52. doi:https://doi.org/10.1007/s10571-007-9181-x
- Amagase H, Sun B, Borek C. Lycium barbarum (goji) juice improves in vivo antioxidant biomarkers in serum of healthy adults. Nutr Res. 2009;29(1):19–25. doi:https://doi.org/10.1016/j.nutres.2008.11.005
- Zhang Q, Lv X, Wu T, Ma Q, Teng A, Zhang Y, Zhang M. Composition of Lycium barbarum polysaccharides and their apoptosis-inducing effect on human hepatoma SMMC-7721 cells. Food Nutr Res. 2015;59:28696. doi:https://doi.org/10.3402/fnr.v59.28696
- Ceccarini MR, Vannini S, Cataldi S, Moretti M, Villarini M, Fioretti B, Albi E, Beccari T, Codini M. In vitro protective effects of Lycium barbarum berries cultivated in Umbria (Italy) on human hepatocellular carcinoma cells. Bio Med Res Int. 2016;2016:7529521.
- Chen J-H, Tipoe GL, Liong EC, So HSH, Leung K-M, Tom W-M, Fung PCW, Nanji AA. Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants. Am J Clin Nutr. 2004;80(3):742–751. doi:https://doi.org/10.1093/ajcn/80.3.742
- Darvesh AS, Bishayee A. Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer. Nutr Cancer. 2013;65(3):329–344. doi:https://doi.org/10.1080/01635581.2013.767367
- Kuo PL, Lin CC. Green tea constituent (-)-epigallocatechin-3-gallate inhibits Hep G2 cell proliferation and induces apoptosis through p53-dependent and Fas-mediated pathways. J Biomed Sci. 2003;10(2):219–227. doi:https://doi.org/10.1007/BF02256057
- Shimizu M, Shirakami Y, Sakai H, Tatebe H, Nakagawa T, Hara Y, Weinstein IB, Moriwaki H. EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells. Cancer Lett. 2008;262(1):10–8. doi:https://doi.org/10.1016/j.canlet.2007.11.026
- Chen C, Yu R, Owuor ED, Kong AN. Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch Pharmacal Res. 2000;23(6):605–612. doi:https://doi.org/10.1007/BF02975249
- Sumi T, Shirakami Y, Shimizu M, Kochi T, Ohno T, Kubota M, Shiraki M, Tsurumi H, Tanaka T, Moriwaki H. (-)-Epigallocatechin-3-gallate suppresses hepatic preneoplastic lesions developed in a novel rat model of non-alcoholic steatohepatitis. Springer Plus. 2013;2:690. doi:https://doi.org/10.1186/2193-1801-2-690
- Li S, Wu L, Feng J, Li J, Liu T, Zhang R, Xu S, Cheng K, Zhou Y, Zhou S, et al. In vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity. Sci Rep. 2016;6:28479. doi:https://doi.org/10.1038/srep28479
- Ghosh S, Rangan L. Alpinia: the gold mine of future therapeutics. 3 Biotech. 2013;3(3):173–185. doi:https://doi.org/10.1007/s13205-012-0089-x
- An N, Zou Z-m, Tian Z, Luo X-z, Yang S-l, Xu L-z. Diarylheptanoids from the rhizomes of Alpinia officinarum and their anticancer activity. Fitoterapia. 2008;79(1):27–31. doi:https://doi.org/10.1016/j.fitote.2007.07.001
- Zhang HT, Wu J, Wen M, Su LJ, Luo H. Galangin induces apoptosis in hepatocellular carcinoma cells through the caspase 8/t-Bid mitochondrial pathway. J Asian Nat Prod Res. 2012;14(7):626–633. doi:https://doi.org/10.1080/10286020.2012.682152
- Elgazar AA, Selim NM, Abdel‐Hamid NM, El‐Magd MA, El Hefnawy HM. Isolates from Alpinia officinarum Hance attenuate LPS-induced inflammation in HepG2: evidence from in silico and in vitro studies. Phytother Res. 2018;32(7):1273–1288. doi:https://doi.org/10.1002/ptr.6056
- Abass SA, Abdel-Hamid NM, Abouzed TK, El-Shishtawy MM. Chemosensitizing effect of Alpinia officinarum rhizome extract in cisplatin-treated rats with hepatocellular carcinoma. Biomed Pharmacother. 2018;101:710–718. doi:https://doi.org/10.1016/j.biopha.2018.02.128
- Sule A, Ahmed QU, Latip J, Samah OA, Omar MN, Umar A, Dogarai BBS. Antifungal activity of Andrographis paniculata extracts and active principles against skin pathogenic fungal strains in vitro. Pharm Biol. 2012;50(7):850–856. doi:https://doi.org/10.3109/13880209.2011.641021
- Neha T, Rawal UM. Effect of aqueous extract of Andrographis paniculata on liver tumor. Ind J Pharmacol. 1998;30:318.
- Vojdani A, Erde J. Regulatory T cells, a potent immunoregulatory target for CAM researchers: modulating tumor immunity, autoimmunity and alloreactive immunity (III). Evid Complement Alternat Med. 2006;3(3):309–316. doi:https://doi.org/10.1093/ecam/nel047
- Geethangili M, Rao YK, Fang SH, Tzeng YM. Cytotoxic constituents from Andrographis paniculata induce cell cycle arrest in jurkat cells. Phytother Res. 2008;22(10):1336–1341. doi:https://doi.org/10.1002/ptr.2493
- Shi M-D, Lin H-H, Lee Y-C, Chao J-K, Lin R-A, Chen J-H. Inhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by andrographolide. Chem Biol Interact. 2008;174(3):201–210. doi:https://doi.org/10.1016/j.cbi.2008.06.006
- Zhou J, Zhang S, Choon-Nam O, Shen HM. Critical role of pro-apoptotic Bcl-2 family members in andrographolide-induced apoptosis in human cancer cells. Biochem Pharmacol. 2006;72(2):132–144. doi:https://doi.org/10.1016/j.bcp.2006.04.019
- Sato H, Goto W, Yamamura J, Kurokawa M, Kageyama S, Takahara T, Watanabe A, Shiraki K. Therapeutic basis of glycyrrhizin on chronic hepatitis B. Antiviral Res. 1996;30(2-3):171–177. doi:https://doi.org/10.1016/0166-3542(96)00942-4
- Arase Y, Ikeda K, Murashima N, Chayama K, Tsubota A, Koida I, Suzuki Y, Saitoh S, Kobayashi M, Kumada H. The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer. 1997;79(8):1494–1500. doi:https://doi.org/10.1002/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-B
- Shiota G, Harada K-i, Ishida M, Tomie Y, Okubo M, Katayama S, Ito H, Kawasaki H. Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine-treated mice. Carcinogenesis. 1999;20(1):59–63. doi:https://doi.org/10.1093/carcin/20.1.59
- Paolini M, Barillari J, Broccoli M, Pozzetti L, Perocco P, Cantelli-Forti G. Effect of liquorice and glycyrrhizin on rat liver carcinogen metabolizing enzymes. Cancer Lett. 1999;145(1-2):35–42. doi:https://doi.org/10.1016/s0304-3835(99)00225-6
- Shi L, Tang C, Yin C. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma. Biomaterials. 2012;33(30):7594–7604. doi:https://doi.org/10.1016/j.biomaterials.2012.06.072
- Hemieda F, Serag H, El-Baz E, Ramadan S, Faried AE, Hemieda S. Therapeutic efficacy of licorice and/or cisplatin against diethylnitrosamine and carbon tetrachloride-induced hepatocellular carcinoma in rats. J Am Sci. 2016;12:10–19.
- Zhang Y, Yan C, Li Y, Mao X, Tao W, Tang Y, Lin Y, Guo Q, Duan J, Lin N. Therapeutic effects of Euphorbia Pekinensis and Glycyrrhiza glabra on hepatocellular carcinoma ascites partially via regulating the Frk-Arhgdib-Inpp5d-Avpr2-Aqp4 signal axis. Sci Rep. 2017;7:41925. doi:https://doi.org/10.1038/srep41925
- Banerjee S, Azmi AS, Padhye S, Singh MW, Baruah JB, Philip PA, Sarkar FH, Mohammad RM. Structure-activity studies on therapeutic potential of thymoquinone analogs in pancreatic cancer. Pharm Res. 2010;27(6):1146–1158. doi:https://doi.org/10.1007/s11095-010-0145-3
- Randhawa MA, Alghamdi MS. Anticancer activity of Nigella sativa (black seed)—a review. Am J Chin Med. 2011;39(6):1075–1091. doi:https://doi.org/10.1142/S0192415X1100941X
- Swamy SM, Tan BK. Cytotoxic and immunopotentiating effects of ethanolic extract of Nigella sativa L. seeds. J Ethnopharmacol. 2000;70(1):1–7. doi:https://doi.org/10.1016/S0378-8741(98)00241-4
- Salomi NJ, Nair SC, Jayawardhanan KK, Varghese CD, Panikkar KR. Antitumour principles from Nigella sativa seeds. Cancer Lett. 1992;63(1):41–46. doi:https://doi.org/10.1016/0304-3835(92)90087-c
- Majdalawieh AF, Fayyad MW. Recent advances on the anti-cancer properties of Nigella sativa, a widely used food additive. J Ayurveda Integr Med. 2016;7(3):173–180. doi:https://doi.org/10.1016/j.jaim.2016.07.004
- Iddamaldeniya SS, Wickramasinghe N, Thabrew I, Ratnatunge N, Thammitiyagodage MG. Protection against diethylnitrosoamine-induced hepatocarcinogenesis by an indigenous medicine comprised of Nigella sativa, Hemidesmus indicus and Smilax glabra: a preliminary study. J Carcinog. 2003;2(1):6. doi:https://doi.org/10.1186/1477-3163-2-6
- Abdel-Hamid NM, Abdel-Ghany MI, Nazmy MH, Amgad SW. Can methanolic extract of Nigella sativa seed affect glyco-regulatory enzymes in experimental hepatocellular carcinoma? Environ Health Prev Med. 2013;18(1):49–56. doi:https://doi.org/10.1007/s12199-012-0292-8
- Khan F, Kalamegam G, Gari M, Abuzenadah A, Chaudhary A, Al Qahtani M, Al Ghamdi K, Jamal T, Al Malki A, Kumosani T. Evaluation of the effect of Nigella sativa extract on human hepatocellular adenocarcinoma cell line (HepG2) in vitro. BMC Genomics. 2014;15(Suppl 2):P63. doi:https://doi.org/10.1186/1471-2164-15-S2-P63
- Wei L, Hua R, Li M, Huang Y, Li S, He Y, Shen Z. Chemical composition and biological activity of star anise Illicium verum extracts against maize weevil, Sitophilus zeamais adults. J Insect Sci. 2014;14:80. doi:https://doi.org/10.1093/jis/14.1.80
- Chouksey D, Sharma P, Pawar RS. Biological activities and chemical constituents of Illicium verum hook fruits (Chinese star anise). Der Pharmacia Sin. 2010;1:1–10.
- Yang CH, Chang FR, Chang HW, Wang SM, Hsieh MC, Chuang L-Y. Investigation of the antioxidant activity of Illicium verum extracts. J Med Plants Res. 2012;6:314–324.
- Asif M, Yehya AHS, Al-Mansoub MA, Revadigar V, Ezzat MO, Khadeer Ahamed MB, Oon CE, Murugaiyah V, Abdul Majid AS, Abdul Majid AMS. Anticancer attributes of Illicium verum essential oils against colon cancer. South Afr J Bot. 2016;103:156–161. doi:https://doi.org/10.1016/j.sajb.2015.08.017
- Lombardi VR, Carrera I, Cacabelos R. In vitro screening for cytotoxic activity of herbal extracts. Evid Complement Alternat Med. 2017;2017:2675631. doi:https://doi.org/10.1155/2017/2675631
- Yadav AS, Bhatnagar D. Chemo-preventive effect of Star anise in N-nitrosodiethylamine initiated and phenobarbital promoted hepato-carcinogenesis. Chem Biol Interact. 2007;169(3):207–214. doi:https://doi.org/10.1016/j.cbi.2007.06.032
- Wang CZ, Qi LW, Yuan CS. Cancer chemoprevention effects of ginger and its active constituents: potential for new drug discovery. Am J Chin Med. 2015;43(7):1351–1363. doi:https://doi.org/10.1142/S0192415X15500767
- Choudhury D, Das A, Bhattacharya A, Chakrabarti G. Aqueous extract of ginger shows antiproliferative activity through disruption of microtubule network of cancer cells. Food Chem Toxicol. 2010;48(10):2872–2880. doi:https://doi.org/10.1016/j.fct.2010.07.020
- Mansour MA, Bekheet SA, Al-Rejaie SS, Al-Shabanah OA, Al-Howiriny TA, Al-Rikabi AC, Abdo AA. Ginger ingredients inhibit the development of diethylnitrosoamine induced premalignant phenotype in rat chemical hepatocarcinogenesis model. Biofactors. 2010;36(6):483–490. doi:https://doi.org/10.1002/biof.122
- Padma VV, Christie SAD, Ramkuma KM. Induction of apoptosis by ginger in HEp-2 cell line is mediated by reactive oxygen species. Basic Clin Pharmacol Toxicol. 2007;100(5):302–307. doi:https://doi.org/10.1111/j.1742-7843.2007.00046.x
- Chen C-Y, Liu T-Z, Liu Y-W, Tseng W-C, Liu RH, Lu F-J, Lin Y-S, Kuo S-H, Chen C-H. 6-shogaol (alkanone from ginger) induces apoptotic cell death of human hepatoma p53 mutant Mahlavu subline via an oxidative stress-mediated caspase-dependent mechanism. J Agric Food Chem. 2007;55(3):948–954. doi:https://doi.org/10.1021/jf0624594
- Habib SHM, Makpol S, Hamid NAA, Das S, Ngah WZW, Yusof YAM. Ginger extract (Zingiber officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats. Clinics. 2008;63(6):807–813. doi:https://doi.org/10.1590/S1807-59322008000600017
- Jeena KO, Liju VB, Kuttan RA. Antioxidant, anti-inflammatory and antinociceptive activities of essential oil from ginger. Ind J Physiol Pharmacol. 2013;57:51–62.
- Hu R, Zhou P, Peng Y-B, Xu X, Ma J, Liu Q, Zhang L, Wen X-D, Qi L-W, Gao N, et al. 6-Shogaol induces apoptosis in human hepatocellular carcinoma cells and exhibits anti-tumor activity in vivo through endoplasmic reticulum stress. PloS One. 2012;7(6):e39664. doi:https://doi.org/10.1371/journal.pone.0039664
- Yang G, Wang S, Zhong L, Dong X, Zhang W, Jiang L, Geng C, Sun X, Liu X, Chen M, et al. 6-Gingerol induces apoptosis through lysosomal-mitochondrial axis in human hepatoma G2 cells. Phytother Res. 2012;26(11):1667–1673. doi:https://doi.org/10.1002/ptr.4632
- Yusof Y, Ahmad N, Das S, Sulaiman S, Murad N. Chemopreventive efficacy of ginger (Zingiber officinale) in ethionine induced rat hepatocarcinogenesis. Afr J Tradit Complement Altern Med. 2009;6:87–93.
- Weng CJ, Chou CP, Ho CT, Yen GC. Molecular mechanism inhibiting human hepatocarcinoma cell invasion by 6-shogaol and 6-gingerol . Mol Nutr Food Res. 2012;56(8):1304–1314. doi:https://doi.org/10.1002/mnfr.201200173
- Cartea ME, Francisco M, Soengas P, Velasco P. Phenolic compounds in Brassica vegetables. Molecules. 2010;16(1):251–280. doi:https://doi.org/10.3390/molecules16010251
- El-Awady AA, Saber WI, Hamid NM, Hassan HA. Increasing antioxidant content of broccoli sprouts using essential oils during cold storage. Agriculture. 2016;62(3):111–126. doi:https://doi.org/10.1515/agri-2016-0012
- Guerrero-Beltrán CE, Calderón-Oliver M, Pedraza-Chaverri J, Chirino YI. Protective effect of sulforaphane against oxidative stress: recent advances. Exp Toxicol Pathol. 2012;64(5):503–508. doi:https://doi.org/10.1016/j.etp.2010.11.005
- Baenas N, Silván JM, Medina S, García-Viguera C, Moreno DA, de Pascual-Teresa S. Antiproliferative effects and metabolism of sulforaphane and glucoraphanin from broccoli sprouts in human colon and liver cancer cells. In II International Congress, Food Technology, Quality and Safety. Proceedings, 28–30 October 2014, Novi Sad, Serbia; 2014. p. 451–456.
- Kikuchi M, Ushida Y, Shiozawa H, Umeda R, Tsuruya K, Aoki Y, Suganuma H, Nishizaki Y. Sulforaphane-rich broccoli sprout extract improves hepatic abnormalities in male subjects. World J Gastroenterol. 2015;21(43):12457–12467. doi:https://doi.org/10.3748/wjg.v21.i43.12457
- Davis-Searles PR, Nakanishi Y, Kim N-C, Graf TN, Oberlies NH, Wani MC, Wall ME, Agarwal R, Kroll DJ. Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells. Cancer Res. 2005;65(10):4448–4457. doi:https://doi.org/10.1158/0008-5472.CAN-04-4662
- Varghese L, Agarwal C, Tyagi A, Singh RP, Agarwal R. Silibinin efficacy against human hepatocellular carcinoma. Clin Cancer Res. 2005;11(23):8441–8448. doi:https://doi.org/10.1158/1078-0432.CCR-05-1646
- Ramakrishnan G, Augustine TA, Jagan S, Vinodhkumar R, Devaki T. Effect of silymarin on N-nitrosodiethylamine induced hepatocarcinogenesis in rats. Exp Oncol. 2007;29:39–44.
- Ramakrishnan G, Lo Muzio L, Elinos-Báez CM, Jagan S, Augustine TA, Kamaraj S, Anandakumar P, Devaki T. Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells. Cell Prolif. 2009;42(2):229–240. doi:https://doi.org/10.1111/j.1365-2184.2008.00581.x
- Bousserouel S, Bour G, Kauntz H, Gosse F, Marescaux J, Raul F. Silibinin inhibits tumor growth in a murine orthotopic hepatocarcinoma model and activates the TRAIL apoptotic signaling pathway. Anticancer Res. 2012;32:2455–2462.
- Brandon-Warner E, Eheim AL, Foureau DM, Walling TL, Schrum LW, McKillop IH. Silibinin (Milk Thistle) potentiates ethanol-dependent hepatocellular carcinoma progression in male mice. Cancer Lett. 2012;326(1):88–95. doi:https://doi.org/10.1016/j.canlet.2012.07.028
- Gopalakrishnan R, Sundaram J, Sattu K, Pandi A, Thiruvengadam D. Dietary supplementation of silymarin is associated with decreased cell proliferation, increased apoptosis, and activation of detoxification system in hepatocellular carcinoma. Mol Cell Biochem. 2013;377(1-2):163–176. doi:https://doi.org/10.1007/s11010-013-1582-1
- Zhang H, Wang CB, Liu JL. Silybin nanoparticles for liver cancer: development, optimization and in vitro–in vivo evaluation. J Buon. 2016;21(3):633–644.
- Ahmad U, Akhtar J, Singh SP, Ahmad FJ, Siddiqui S. Silymarin nanoemulsion against human hepatocellular carcinoma: development and optimization. Artificial Cells Nanomed Biotechnol. 2018;46(2):231–241. doi:https://doi.org/10.1080/21691401.2017.1324465
- Wu L, Li J, Liu T, Li S, Feng J, Yu Q, Zhang J, Chen J, Zhou Y, Ji J, et al. Quercetin shows anti-tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway. Cancer Med. 2019;8(10):4806–4820. doi:https://doi.org/10.1002/cam4.2388
- Ding Y, Chen X, Wang B, Yu B, Ge J, Shi X. Quercetin suppresses the chymotrypsin-like activity of proteasome via inhibition of MEK1/ERK1/2 signaling pathway in hepatocellular carcinoma HepG2 cells. Can J Physiol Pharmacol. 2018;96(5):521–526. doi:https://doi.org/10.1139/cjpp-2017-0655
- Pi J, Li B, Tu L, Zhu H, Jin H, Yang F, Bai H, Cai H, Cai J. Investigation of quercetin-induced HepG2 cell apoptosis-associated cellular biophysical alterations by atomic force microscopy. Scanning. 2016;38(2):100–112. doi:https://doi.org/10.1002/sca.21245
- Maurya AK, Vinayak M. Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line. Mol Biol Rep. 2015;42(9):1419–1429. doi:https://doi.org/10.1007/s11033-015-3921-7
- Granado-Serrano AB, Martín MA, Bravo L, Goya L, Ramos S. Quercetin modulates NF-κ B and AP-1/JNK pathways to induce cell death in human hepatoma cells. Nutr Cancer. 2010;62(3):390–401. doi:https://doi.org/10.1080/01635580903441196
- Ren K-W, Li Y-H, Wu G, Ren J-Z, Lu H-B, Li Z-M, Han X-W. Quercetin nanoparticles display antitumor activity via proliferation inhibition and apoptosis induction in liver cancer cells. Int J Oncol. 2017;50(4):1299–1311. doi:https://doi.org/10.3892/ijo.2017.3886
- Bishayee K, Khuda-Bukhsh AR, Huh SO. PLGA-loaded gold-nanoparticles precipitated with quercetin downregulate HDAC-Akt activities controlling proliferation and activate p53-ROS crosstalk to induce apoptosis in hepatocarcinoma cells. Mol Cells. 2015;38(6):518–527. doi:https://doi.org/10.14348/molcells.2015.2339
- Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci. 2009;30(2):85–94. doi:https://doi.org/10.1016/j.tips.2008.11.002
- Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41(1):40–59. doi:https://doi.org/10.1016/j.biocel.2008.06.010
- Cao J, Liu Y, Jia L, Zhou H-M, Kong Y, Yang G, Jiang L-P, Li Q-J, Zhong L-F. Curcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells. Free Radic Biol Med. 2007;43(6):968–975. doi:https://doi.org/10.1016/j.freeradbiomed.2007.06.006
- Yoysungnoen P, Wirachwong P, Changtam C, Suksamrarn A, Patumraj S. Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice. World J Gastroenterol. 2008;14(13):2003–2209. doi:https://doi.org/10.3748/wjg.14.2003
- Xu MX, Zhao L, Deng C, Yang L, Wang Y, Guo T, Li L, Lin J, Zhang L. Curcumin suppresses proliferation and induces apoptosis of human hepatocellular carcinoma cells via the wnt signaling pathway. Int J Oncol. 2013;43(6):1951–1959. doi:https://doi.org/10.3892/ijo.2013.2107
- Hassan SK, Mousa AM, Eshak MG, Farrag AE, Badawi AE. Therapeutic and chemopreventive effects of nano curcumin against diethylnitrosamine induced hepatocellular carcinoma in rats. Int J Pharm Pharm Sci. 2014;6:54–62.
- Pan Z, Zhuang J, Ji C, Cai Z, Liao W, Huang Z. Curcumin inhibits hepatocellular carcinoma growth by targeting VEGF expression. Oncol Lett. 2018;15(4):4821–4826. doi:https://doi.org/10.3892/ol.2018.7988
- Teng C-F, Yu C-H, Chang H-Y, Hsieh W-C, Wu T-H, Lin J-H, Wu H-C, Jeng L-B, Su I-J. Chemopreventive effect of phytosomal curcumin on hepatitis B virus-related hepatocellular carcinoma in a transgenic mouse model. Sci Rep. 2019;9(1):1–3. doi:https://doi.org/10.1038/s41598-019-46891-5
- Notarbartolo M, Poma P, Perri D, Dusonchet L, Cervello M, D’Alessandro N. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. Cancer Lett. 2005;224(1):53–65. doi:https://doi.org/10.1016/j.canlet.2004.10.051
- Darvesh AS, Aggarwal BB, Bishayee A. Curcumin and liver cancer: a review. Curr Pharm Biotechnol. 2012;13(1):218–228. doi:https://doi.org/10.2174/138920112798868791
- Liou C-J, Lai X-Y, Chen Y-L, Wang C-L, Wei C-H, Huang W-C. Curcumin induces p53-null hepatoma cell line Hep3B apoptosis through the AKT-PTEN-FOXO4 pathway. Evid Based Complement Alternat Med. 2017;2017:1–12. doi:https://doi.org/10.1155/2017/4293429
- Keylor MH, Matsuura BS, Stephenson CR. Chemistry and biology of resveratrol-derived natural products. Chem Rev. 2015;115(17):8976–9027. doi:https://doi.org/10.1021/cr500689b
- Notas G, Nifli A-P, Kampa M, Vercauteren J, Kouroumalis E, Castanas E. Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation. Biochim Biophys Acta. 2006;1760(11):1657–1666. doi:https://doi.org/10.1016/j.bbagen.2006.09.010
- Michels G, Wätjen W, Weber N, Niering P, Chovolou Y, Kampkötter A, Proksch P, Kahl R. Resveratrol induces apoptotic cell death in rat H4IIE hepatoma cells but necrosis in C6 glioma cells. Toxicology. 2006;225(2-3):173–182. doi:https://doi.org/10.1016/j.tox.2006.05.014
- Yeh C-B, Hsieh M-J, Lin C-W, Chiou H-L, Lin P-Y, Chen T-Y, Yang S-F. The antimetastatic effects of resveratrol on hepatocellular carcinoma through the downregulation of a metastasis-associated protease by SP-1 modulation. PLoS One. 2013;8(2):e56661. doi:https://doi.org/10.1371/journal.pone.0056661
- Li T, Wang W, Li T. The mechanism of resveratrol on anti-hepatoma Bel-7402 and modulating IL-8 in tumor model mice. Zhong Yao Cai. 2008;31(5):697–702.
- Bishayee A. The role of inflammation and liver cancer. Adv Exp Med Biol. 2014;816:401–435. doi:https://doi.org/10.1007/978-3-0348-0837-8_16
- Mbimba T, Awale P, Bhatia D, Geldenhuys WJ, Darvesh AS, Carroll RT, Bishayee A. Alteration of hepatic proinflammatory cytokines is involved in the resveratrol-mediated chemoprevention of chemically-induced hepatocarcinogenesis. Curr Pharm Biotechnol. 2012;13(1):229–234. doi:https://doi.org/10.2174/138920112798868575
- Lin H-C, Chen Y-F, Hsu W-H, Yang C-W, Kao C-H, Tsai T-F. Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model. Cancer Prev Res. 2012;5(7):952–962. doi:https://doi.org/10.1158/1940-6207.CAPR-12-0001
- Hibbs K, Skubitz KM, Pambuccian SE, Casey RC, Burleson KM, Oegema TR, Thiele JJ, Grindle SM, Bliss RL, Skubitz APN. Differential gene expression in ovarian carcinoma: identification of potential biomarkers. Am J Pathol. 2004;165(2):397–414. doi:https://doi.org/10.1016/S0002-9440(10)63306-8
- Ji B-C, Hsu W-H, Yang J-S, Hsia T-C, Lu C-C, Chiang J-H, Yang J-L, Lin C-H, Lin J-J, Suen L-JW, et al. Gallic acid induces apoptosis via caspase-3 and mitochondrion-dependent pathways in vitro and suppresses lung xenograft tumor growth in vivo. J Agric Food Chem. 2009;57(16):7596–7604. doi:https://doi.org/10.1021/jf901308p
- Govea-Salas M, Rivas-Estilla AM, Rodríguez-Herrera R, Lozano-Sepúlveda SA, Aguilar-Gonzalez CN, Zugasti-Cruz A, Salas-Villalobos TB, Morlett-Chávez JA. Gallic acid decreases hepatitis C virus expression through its antioxidant capacity. Exp Ther Med. 2016;11(2):619–624. doi:https://doi.org/10.3892/etm.2015.2923
- Liu G, Xiong S, Xiang Y-F, Guo C-W, Ge F, Yang C-R, Zhang Y-J, Wang Y-F, Kitazato K. Antiviral activity and possible mechanisms of action of pentagalloylglucose (PGG) against influenza A virus. Arch Virol. 2011;156(8):1359–1369. doi:https://doi.org/10.1007/s00705-011-0989-9
- Kawada M, Ohno Y, Ri Y, Ikoma T, Yuugetu H. Anti-tumor effect of gallic acid on LL-2 lung cancer cells transplanted in mice. Anti-Cancer Drugs. 2001;12:847–852.
- Sun G, Zhang S, Xie Y, Zhang Z, Zhao W. Gallic acid as a selective anticancer agent that induces apoptosis in SMMC-7721 human hepatocellular carcinoma cells. Oncol Lett. 2016;11(1):150–158. doi:https://doi.org/10.3892/ol.2015.3845
- Aglan HA, Ahmed HH, El-Toumy SA, Mahmoud NS. Gallic acid against hepatocellular carcinoma: an integrated scheme of the potential mechanisms of action from in vivo study. Tumor Biol. 2017;39(6):1010428317699127. doi:https://doi.org/10.1177/1010428317699127
- Guamán Ortiz LM, Lombardi P, Tillhon M, Scovassi AI. Berberine, an epiphany against cancer. Molecules. 2014;19(8):12349–12367. doi:https://doi.org/10.3390/molecules190812349
- Huang CH, Huang ZW, Ho FM, Chan WH. Berberine impairs embryonic development in vitro and in vivo through oxidative stress-mediated apoptotic processes. Environ Toxicol. 2018;33(3):280–294. doi:https://doi.org/10.1002/tox.22515
- Auyeung KK, Ko JK. Coptis chinensis inhibits hepatocellular carcinoma cell growth through nonsteroidal anti-inflammatory drug-activated gene activation. Int J Mol Med. 2009;24(4):571–577. doi:https://doi.org/10.3892/ijmm_00000267
- Lin Y-C, Kuo J-Y, Hsu C-C, Tsai W-C, Li W-C, Yu M-C, Wen H-W. Optimizing manufacture of liposomal berberine with evaluation of its antihepatoma effects in a murine xenograft model. Int J Pharm. 2013;441(1-2):381–388. doi:https://doi.org/10.1016/j.ijpharm.2012.11.017
- Li J, Li O, Kan M, Zhang M, Shao D, Pan Y, Zheng H, Zhang X, Chen L, Liu S. Berberine induces apoptosis by suppressing the arachidonic acid metabolic pathway in hepatocellular carcinoma. Mol Med Rep. 2015;12(3):4572–4577. doi:https://doi.org/10.3892/mmr.2015.3926
- Wang ZP, Wu J, Ts C, Zhou Q, Wang YF. In vitro and in vivo antitumor efficacy of berberine-nanostructured lipid carriers against H22 tumor. Biophoton Immune Responses X. 2015;9324:93240Y.
- Chuang T-Y, Wu H-L, Min J, Diamond M, Azziz R, Chen Y-H. Berberine regulates the protein expression of multiple tumorigenesis-related genes in hepatocellular carcinoma cell lines. Cancer Cell Int. 2017;17:59. doi:https://doi.org/10.1186/s12935-017-0429-3
- Li F, Dong X, Lin P, Jiang J. Regulation of Akt/FoxO3a/Skp2 axis is critically involved in berberine-induced cell cycle arrest in hepatocellular carcinoma cells. Int J Mol Sci. 2018;19:327.
- Dai B, Ma Y, Yang T, Fan M, Yu R, Su Q, Wang H, Liu F, Yang C, Zhang Y. Synergistic effect of berberine and HMQ1611 impairs cell proliferation and migration by regulating Wnt signaling pathway in hepatocellular carcinoma. Phytother Res. 2019;33(3):745–755. doi:https://doi.org/10.1002/ptr.6267
- Li F, Dong X, Lin P, Jiang J. Regulation of Akt/FoxO3a/Skp2 axis is critically involved in berberine-induced cell cycle arrest in hepatocellular carcinoma cells. J Mol Sci. 2018;19:327.
- Saxena S, Shukla S, Kakkar P. Berberine induced modulation of PHLPP2-Akt-MST1 kinase signaling is coupled with mitochondrial impairment and hepatoma cell death. Toxicol Appl Pharmacol. 2018;347:92–103. doi:https://doi.org/10.1016/j.taap.2018.03.033
- Huang Y, Wang K, Gu C, Yu G, Zhao D, Mai W, Zhong Y, Liu S, Nie Y, Yang H. Berberine, a natural plant alkaloid, synergistically sensitizes human liver cancer cells to sorafenib. Oncol Rep. 2018;40(3):1525–1532. doi:https://doi.org/10.3892/or.2018.6552
- Yuan S-L, Wei Y-Q, Wang X-J, Xiao F, Li S-F, Zhang J. Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cells. World J Gastroenterol. 2004;10(14):2024–2028. doi:https://doi.org/10.3748/wjg.v10.i14.2024
- Cao EH, Liu XQ, Wang JJ, Xu NF. Effect of natural antioxidant tanshinone II-A on DNA damage by lipid peroxidation in liver cells. Free Rad Biol Med. 1996;20(6):801–806. doi:https://doi.org/10.1016/0891-5849(95)02211-2
- Zhao BL, Jiang W, Zhao Y, Hou JW, Xin WJ. Scavenging effects of Salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury. Biochem Mol Biol Int. 1996;38(6):1171–1182.
- Wang X, Yuan S, Huang R, Song Y. An observation of the effect of tanshinone on cancer cell proliferation by Brdu and PCNA labeling. Hua Xi Yi Ke Da Xue Xue Bao. 1996;27:388–391.
- Li Q, Wang Y, Feng N, Fan Z, Sun J, Nan Y. Novel polymeric nanoparticles containing tanshinone IIA for the treatment of hepatoma. J Drug Targeting. 2008;16(10):725–732. doi:https://doi.org/10.1080/10611860802374303
- Wang W-Q, Liu L, Sun H-C, Fu Y-L, Xu H-X, Chai Z-T, Zhang Q-B, Kong L-Q, Zhu X-D, Lu L, et al. Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization. J Hematol Oncol. 2012;5:69. doi:https://doi.org/10.1186/1756-8722-5-69
- Oztürk Y, Günaydın C, Yalçın F, Nazıroğlu M, Braidy N. Resveratrol enhances apoptotic and oxidant effects of paclitaxel through TRPM2 channel activation in DBTRG glioblastoma cells. Oxid Med Cell Longev. 2019;2019:4619865. doi:https://doi.org/10.1155/2019/4619865
- Manjavachi MN, Passos GF, Trevisan G, Araújo SB, Pontes JP, Fernandes ES, Costa R, Calixto JB. Spinal blockage of CXCL1 and its receptor CXCR2 inhibits paclitaxel-induced peripheral neuropathy in mice. Neuropharmacol. 2019;151:136–143. doi:https://doi.org/10.1016/j.neuropharm.2019.04.014
- Liang H-F, Chen C-T, Chen S-C, Kulkarni AR, Chiu Y-L, Chen M-C, Sung H-W. Paclitaxel-loaded poly (γ-glutamic acid)-poly (lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Biomaterials. 2006;27(9):2051–2059. doi:https://doi.org/10.1016/j.biomaterials.2005.10.027
- Byam J, Renz J, Millis JM. Liver transplantation for hepatocellular carcinoma. Hepatobiliary Surg Nutr. 2013;2(1):22–30. doi:https://doi.org/10.3978/j.issn.2304-3881.2012.11.03
- Zhou M, Li Z, Han Z, Tian N. Paclitaxel-sensitization enhanced by curcumin involves down-regulation of nuclear factor-κB and Lin28 in Hep3B cells. J Recept Signal Transduct Res. 2015;35(6):618–625. doi:https://doi.org/10.3109/10799893.2015.1041644
- Zhu M, Li W, Lu Y, Dong X, Chen Y, Lin B, Xie X, Guo J, Li M. Alpha fetoprotein antagonizes apoptosis induced by paclitaxel in hepatoma cells in vitro. Sci Rep. 2016;6:26472. doi:https://doi.org/10.1038/srep26472
- Ji X, Shen Y, Sun H, Gao X. A novel anti-alpha-fetoprotein single-chain variable fragment displays anti-tumor effects in HepG2 cells as a single agent or in combination with paclitaxel. Tumor Biol. 2016;37(8):10085–10096. doi:https://doi.org/10.1007/s13277-016-4803-x
- Wang D, Zhang S, Zhang T, Wan G, Chen B, Xiong Q, Zhang J, Zhang W, Wang Y. Pullulan-coated phospholipid and pluronic F68 complex nanoparticles for carrying IR780 and paclitaxel to treat hepatocellular carcinoma by combining photothermal therapy/photodynamic therapy and chemotherapy. Int J Nanomed. 2017;12:8649–8670. doi:https://doi.org/10.2147/IJN.S147591
- Li Y, Guo M, Lin Z, Zhao M, Xiao M, Wang C, Xu T, Chen T, Zhu B. Polyethylenimine-functionalized silver nanoparticle-based co-delivery of paclitaxel to induce HepG2 cell apoptosis. Int J Nanomed. 2016;11:6693–6702. doi:https://doi.org/10.2147/IJN.S122666
- Pang KL, Chin KY. The biological activities of oleocanthal from a molecular perspective. Nutrients. 2018;10(5):570. doi:https://doi.org/10.3390/nu10050570
- Polini B, Digiacomo M, Carpi S, Bertini S, Gado F, Saccomanni G, Macchia M, Nieri P, Manera C, Fogli S. Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer. Toxicol In Vitro. 2018;52:243–250. doi:https://doi.org/10.1016/j.tiv.2018.06.021
- Koga H, Sakisaka S, Ohishi M, Kawaguchi T, Taniguchi E, Sasatomi K, Harada M, Kusaba T, Tanaka M, Kimura R, et al. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology. 1999;29(3):688–696. doi:https://doi.org/10.1002/hep.510290355
- Cusimano A, Balasus D, Azzolina A, Augello G, Emma MR, Di Sano C, Gramignoli R, Strom SC, McCubrey JA, Montalto G, et al. Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation. Int J Oncol. 2017;51(2):533–544. doi:https://doi.org/10.3892/ijo.2017.4049
- Pei T, Meng Q, Han J, Sun H, Li L, Song R, Sun B, Pan S, Liang D, Liu L. (-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma. Oncotarget. 2016;7(28):43475–43491. doi:https://doi.org/10.18632/oncotarget.9782
- Lee SK, Hong C-H, Huh S-K, Kim S-S, Oh O-J, Min H-Y, Park K-K, Chung W-Y, Hwang J-K. Suppressive effect of natural sesquiterpenoids on inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) activity in mouse macrophage cells. J Environ Pathol Toxicol Oncol. 2002;21(2):141–148. doi:https://doi.org/10.1615/JEnvironPatholToxicolOncol.v21.i2.70
- Chung WY, Park JH, Kim MJ, Kim HO, Hwang JK, Lee SK, Park KK. Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-kappa B. Carcinogenesis. 2007;28(6):1224–1231. doi:https://doi.org/10.1093/carcin/bgm005
- Cheah YH, Nordin FJ, Tee TT, Azimahtol HLP, Abdullah NR, Ismail Z. Antiproliferative property and apoptotic effect of xanthorrhizol on MDA-MB-231 breast cancer cells. Anticancer Res. 2008;28(6A):3677–3689.
- Tee TT, Cheah YH, Meenakshii N, Sharom MY, Hawariah LP. Xanthorrhizol induced DNA fragmentation in HepG2 cells involving Bcl-2 family proteins. Biochem Biophys Res Commun. 2012;420(4):834–838. doi:https://doi.org/10.1016/j.bbrc.2012.03.083
- Oon SF, Nallappan M, Tee TT, Shohaimi S, Kassim NK, Sa’ariwijaya MSF, Cheah YH. Xanthorrhizol: a review of its pharmacological activities and anticancer properties. Cancer Cell Int. 2015;15:100. doi:https://doi.org/10.1186/s12935-015-0255-4
- Roy M, Liang L, Xiao X, Feng P, Ye M, Liu J. Lycorine: a prospective natural lead for anticancer drug discovery. Biomed Pharmacother. 2018;107:615–624. doi:https://doi.org/10.1016/j.biopha.2018.07.147
- Zhang P, Zhang M, Yu D, Liu W, Hu L, Zhang B, Zhou Q, Cao Z. Lycorine inhibits melanoma cell migration and metastasis mainly through reducing intracellular levels of β-catenin and matrix metallopeptidase 9. J Cell Physiol. 2019;234(7):10566–10575. doi:https://doi.org/10.1002/jcp.27732
- Yu H, Qiu Y, Pang X, Li J, Wu S, Yin S, Han L, Zhang Y, Jin C, Gao X, et al. Lycorine promotes autophagy and apoptosis via TCRP1/Akt/mTOR axis inactivation in human hepatocellular carcinoma. Mol Cancer Ther. 2017;16(12):2711–2723. doi:https://doi.org/10.1158/1535-7163.MCT-17-0498
- Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 2011;278(1):16–27. doi:https://doi.org/10.1111/j.1742-4658.2010.07919.x
- Liu W, Zhang Q, Tang Q, Hu C, Huang J, Liu Y, Lu Y, Wang Q, Li G, Zhang R. Lycorine inhibits cell proliferation and migration by inhibiting ROCK1/cofilin-induced actin dynamics in HepG2 hepatoblastoma cells. Oncol Rep. 2018;40:2298–2306. doi:https://doi.org/10.3892/or.2018.6609
- Miyamoto T, Matsuzaka T, Shimano H. Rho-associated, coiled-coil-containing protein kinase 1 as a new player in the regulation of hepatic lipogenesis. J Diabetes Investig. 2019;10(5):1165–1167. doi:https://doi.org/10.1111/jdi.13051
- Humphreys L, Espona‐Fiedler M, Longley DB. FLIP as a therapeutic target in cancer. FEBS J. 2018;285(22):4104–4123. doi:https://doi.org/10.1111/febs.14523
- Bolhassani A, Khavari A, Bathaie SZ. Saffron and natural carotenoids: biochemical activities and anti-tumor effects. Biochim Biophys Acta. 2014;1845(1):20–30. doi:https://doi.org/10.1016/j.bbcan.2013.11.001
- Bakshi H, Sam S, Rozati R, Sultan P, Islam T, Rathore B, Lone Z, Sharma M, Triphati J, Saxena RC. DNA fragmentation and cell cycle arrest: a hallmark of apoptosis induced by crocin from Kashmiri saffron in a human pancreatic cancer cell line. Asian Pac J Cancer Prev. 2010;11:675–679.
- Bathaie SZ, Miri H, Mohagheghi M-A, Mokhtari-Dizaji M, Shahbazfar A-A, Hasanzadeh H. Saffron aqueous extract inhibits the chemically-induced gastric cancer progression in the Wistar albino rat. Iran J Basic Med Sci. 2013;16(1):27–38.
- Noureini SK, Wink M. Antiproliferative effects of crocin in HepG2 cells by telomerase inhibition and hTERT down-regulation. Asian Pac J Cancer Prev. 2012;13(5):2305–2309. doi:https://doi.org/10.7314/apjcp.2012.13.5.2305
- Li C-Y, Huang W-F, Wang Q-L, Wang F, Cai E, Hu B, Du J-C, Wang J, Chen R, Cai X-J, et al. Crocetin induces cytotoxicity in colon cancer cells via p53-independent mechanisms. Asian Pac J Cancer Prev. 2012;13(8):3757–3761. doi:https://doi.org/10.7314/apjcp.2012.13.8.3757
- Tseng TH, Chu CY, Huang JM, Shiow SJ, Wang CJ. Crocetin protects against oxidative damage in rat primary hepatocytes. Cancer Lett. 1995;97(1):61–67. doi:https://doi.org/10.1016/0304-3835(95)03964-X
- Amin A, Hamza AA, Bajbouj K, Ashraf SS, Daoud S. Saffron: a potential candidate for a novel anticancer drug against hepatocellular carcinoma. Hepatology. 2011;54(3):857–867. doi:https://doi.org/10.1002/hep.24433
- Amin A, Hamza AA, Daoud S, Khazanehdari K, Hrout AA, Baig B, Chaiboonchoe A, Adrian TE, Zaki N, Salehi-Ashtiani K. Saffron-based crocin prevents early lesions of liver cancer: in vivo, in vitro and network analyses. Recent Pat Anticancer Drug Discov. 2016;11(1):121–133. doi:https://doi.org/10.2174/1574892810666151102110248
- Mansoor TA, Ramalho RM, Luo X, Ramalhete C, Rodrigues CMP, Ferreira M-JU. Isoflavones as apoptosis inducers in human hepatoma HuH-7 cells. Phytother Res. 2011;25(12):1819–1824. doi:https://doi.org/10.1002/ptr.3498
- Neuhouser ML. Dietary flavonoids and cancer risk: evidence from human population studies. Nutr Cancer. 2004;50(1):1–7. doi:https://doi.org/10.1207/s15327914nc5001_1
- Fu L, Xu B-T, Xu X-R, Gan R-Y, Zhang Y, Xia E-Q, Li H-B. Antioxidant capacities and total phenolic contents of 62 fruits. Food Chem. 2011;129(2):345–350. doi:https://doi.org/10.1016/j.foodchem.2011.04.079
- Luo A-J, Wang F-Z, Luo D, Hu D-H, Mao P, Xie W-Z, He X-F, Kan W, Wang Y. Consumption of vegetables may reduce the risk of liver cancer: results from a meta-analysis of case-control and cohort studies. Clin Res Hepatol Gastroenterol. 2015;39(1):45–51. doi:https://doi.org/10.1016/j.clinre.2014.08.003
- Zhang W, Xiang YB, Li HL, Yang G, Cai H, Ji BT, Gao YT, Zheng W, Shu XO. Vegetable-based dietary pattern and liver cancer risk: results from the Shanghai women’s and men’s health studies. Cancer Sci. 2013;104(10):1353–1361. doi:https://doi.org/10.1111/cas.12231
- Lagiou P, Rossi M, Lagiou A, Tzonou A, La Vecchia C, Trichopoulos D. Flavonoid intake and liver cancer: a case-control study in Greece. Cancer Causes Control. 2008;19(8):813–818. doi:https://doi.org/10.1007/s10552-008-9144-7
- Daniell EL, Ryan EP, Brick MA, Thompson HJ. Dietary dry bean effects on hepatic expression of stress and toxicity-related genes in rats. Br J Nutr. 2012;108(S1):S37–S45. doi:https://doi.org/10.1017/S0007114512000815
- Prasad S, Kalra N, Shukla Y. Hepatoprotective effects of lupeol and mango pulp extract of carcinogen induced alteration in Swiss albino mice. Mol Nutr Food Res. 2007;51(3):352–359. doi:https://doi.org/10.1002/mnfr.200600113
- Scola G, Cilene Fernandes Correia Laurino C, Menin E, Salvador M. Suppression of oncoprotein Her-2 and DNA damage after treatment with Flavan-3-ol Vitis labrusca extract. Anticancer Agents Med Chem. 2013;13(7):1088–1095. doi:https://doi.org/10.2174/18715206113139990135
- Feng LL, Liu BX, Zhong JY, Sun LB, Yu HS. Effect of grape procyanidins on tumor angiogenesis in liver cancer xenograft models. Asian Pac J Cancer Prev. 2014;15(2):737–741. doi:https://doi.org/10.7314/apjcp.2014.15.2.737
- Bishayee A, Thoppil RJ, Darvesh AS, Ohanyan V, Meszaros JG, Bhatia D. Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically induced rodent model of hepatocellular carcinogenesis. J Nutr Biochem. 2013;24(1):178–187. doi:https://doi.org/10.1016/j.jnutbio.2012.04.009
- Hara A, Sakata K, Yamada Y, Kuno T, Kitaori N, Oyama T, Hirose Y, Murakami A, Tanaka T, Mori H. Suppression of β-catenin mutation by dietary exposure of auraptene, a citrus antioxidant, in N, N-diethylnitrosamine-induced hepatocellular carcinomas in rats. Oncol Rep. 2005;14(2):345–351.
- Teng BS, Lu YH, Wang ZT, Tao XY, Wei DZ. In vitro anti-tumor activity of isorhamnetin isolated from Hippophae rhamnoides L. against BEL-7402 cells. Pharmacol Res. 2006;54(3):186–194. doi:https://doi.org/10.1016/j.phrs.2006.04.007
- Kim HJ, Yu MH, Lee IS. Inhibitory effects of methanol extract of plum (Prunus salicina L., cv. ‘Soldam’) fruits against benzo(alpha)pyrene-induced toxicity in mice. Food Chem Toxicol. 2008;46(11):3407–3413. doi:https://doi.org/10.1016/j.fct.2008.08.012
- Yu MH, Im HG, Kim HI, Lee IS. Induction of apoptosis by immature plum in human hepatocellular carcinoma. J Med Food. 2009;12(3):518–527. doi:https://doi.org/10.1089/jmf.2008.1268
- Thoppil RJ, Bhatia D, Barnes KF, Haznagy-Radnai E, Hohmann J, Darvesh AS, Bishayee A. Black currant anthocyanins abrogate oxidative stress through Nrf2-mediated antioxidant mechanisms in a rat model of hepatocellular carcinoma. Curr Cancer Drug Targets. 2012;12(9):1244–1257. doi:https://doi.org/10.2174/156800912803987968
- Sudan S, Rupasinghe HV. Flavonoid-enriched apple fraction AF4 induces cell cycle arrest, DNA topoisomerase II inhibition, and apoptosis in human liver cancer HepG2 cells. Nutr Cancer. 2014;66(7):1237–1246. doi:https://doi.org/10.1080/01635581.2014.951733
- Chen Y, Xu S-s, Chen J-w, Wang Y, Xu H-q, Fan N-b, Li X. Anti-tumor activity of Annona squamosa seeds extract containing annonaceous acetogenin compounds. J Ethnopharmacol. 2012;142(2):462–466. doi:https://doi.org/10.1016/j.jep.2012.05.019
- Chang HF, Wu CH, Yang LL. Antitumour and free radical scavenging effects of γ‐mangostin isolated from Garcinia mangostana pericarps against hepatocellular carcinoma cell. J Pharm Pharmacol. 2013;65(9):1419–1428. doi:https://doi.org/10.1111/jphp.12111
- Tien PG, Kayama F, Konishi F, Tamemoto H, Kasono K, Hung NTK, Kuroki M, Ishikawa S-E, Van CN, Kawakami M. Inhibition of tumor growth and angiogenesis by water extract of Gac fruit (Momordica cochinchinensis Spreng). Int J Oncol. 2005;26(4):881–889.
- Friedman M, Levin CE, Lee S-U, Kim H-J, Lee I-S, Byun J-O, Kozukue N. Tomatine-containing green tomato extracts inhibit growth of human breast, colon, liver, and stomach cancer cells. J Agric Food Chem. 2009;57(13):5727–5733. doi:https://doi.org/10.1021/jf900364j
- Gupta P, Bansal MP, Koul A. Evaluating the effect of lycopene from Lycopersicum esculentum on apoptosis during NDEA induced hepatocarcinogenesis. Biochem Biophys Res Commun. 2013;434(3):479–485. doi:https://doi.org/10.1016/j.bbrc.2013.03.099
- Dong M, He X, Liu RH. Phytochemicals of black bean seed coats: isolation, structure elucidation, and their antiproliferative and antioxidative activities. J Agric Food Chem. 2007;55(15):6044–6051. doi:https://doi.org/10.1021/jf070706d
- Razis AF, De Nicola GR, Pagnotta E, Iori R, Ioannides C. 4-Methylsulfanyl-3-butenyl isothiocyanate derived from glucoraphasatin is a potent inducer of rat hepatic phase II enzymes and a potential chemopreventive agent. Arch Toxicol. 2012;86(2):183–194. doi:https://doi.org/10.1007/s00204-011-0750-x
- Friedman M, Lee KR, Kim HJ, Lee IS, Kozukue N. Anticarcinogenic effects of glycoalkaloids from potatoes against human cervical, liver, lymphoma, and stomach cancer cells. J Agric Food Chem. 2005;53(15):6162–6169. doi:https://doi.org/10.1021/jf050620p
- Pasko P, Bukowska-Strakova K, Gdula-Argasinska J, Tyszka-Czochara M. Rutabaga (Brassica napus L. var. napobrassica) seeds, roots, and sprouts: a novel kind of food with antioxidant properties and proapoptotic potential in Hep G2 hepatoma cell line. J Med Food. 2013;16(8):749–759. doi:https://doi.org/10.1089/jmf.2012.0250
- Fang EF, Pan WL, Wong JH, Chan YS, Ye XJ, Ng TB. A new Phaseolus vulgaris lectin induces selective toxicity on human liver carcinoma Hep G2 cells. Arch Toxicol. 2011;85(12):1551–1563. doi:https://doi.org/10.1007/s00204-011-0698-x
- Anwar-Mohamed A, El-Kadi AO. Sulforaphane induces CYP1A1 mRNA, protein, and catalytic activity levels via an AhR-dependent pathway in murine hepatoma Hepa 1c1c7 and human HepG2 cells. Cancer Lett. 2009;275(1):93–101. doi:https://doi.org/10.1016/j.canlet.2008.10.003
- Sultana S, Ahmed S, Jahangir T, Sharma S. Inhibitory effect of celery seeds extract on chemically induced hepatocarcinogenesis: modulation of cell proliferation, metabolism and altered hepatic foci development. Cancer Lett. 2005;221(1):11–20. doi:https://doi.org/10.1016/j.canlet.2004.07.030
- Liu W, Huang X-F, Qi Q, Dai Q-S, Yang L, Nie F-F, Lu N, Gong D-D, Kong L-Y, Guo Q-L. Asparanin A induces G(2)/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells. Biochem Biophys Res Commun. 2009;381(4):700–705. doi:https://doi.org/10.1016/j.bbrc.2009.02.124
- Xiang J, Xiang Y, Lin S, Xin D, Liu X, Weng L, Chen T, Zhang M. Anticancer effects of deproteinized asparagus polysaccharide on hepatocellular carcinoma in vitro and in vivo. Tumor Biol. 2014;35(4):3517–3524. doi:https://doi.org/10.1007/s13277-013-1464-x
- Zhang CZ, Fang EF, Zhang HT, Liu LL, Yun JP. Momordica charantia lectin exhibits antitumor activity towards hepatocellular carcinoma. Investig New Drugs. 2015;33(1):1–11. doi:https://doi.org/10.1007/s10637-014-0156-8
- Fang EF, Zhang CZY, Wong JH, Shen JY, Li CH, Ng TB. The MAP30 protein from bitter gourd (Momordica charantia) seeds promotes apoptosis in liver cancer cells in vitro and in vivo. Cancer Lett. 2012;324(1):66–74. doi:https://doi.org/10.1016/j.canlet.2012.05.005
- Hafidh RR, Abdulamir AS, Bakar FA, Jalilian FA, Abas F, Sekawi Z. Novel molecular, cytotoxical, and immunological study on promising and selective anticancer activity of Mung bean sprouts. BMC Complement Altern Med. 2012;12(1):208. doi:https://doi.org/10.1186/1472-6882-12-208
- Wanga Y, Huangb X, Hanc J, Zhenga W, Maa W. Extract of Perilla frutescens inhibits tumor proliferation of HCC via PI3K/AKT signal pathway. Afr J Trad Complement Alt Med. 2013;10:251–257.
- Sreepriya M, Bali G. Chemopreventive effects of embelin and curcumin against N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in Wistar rats. Fitoterapia. 2005;76(6):549–555. doi:https://doi.org/10.1016/j.fitote.2005.04.014
- Kim J, Ha H-L, Moon H-B, Lee Y-W, Cho C-K, Yoo H-S, Yu D-Y. Chemopreventive effect of Curcuma longa Linn on liver pathology in HBx transgenic mice. Integr Cancer Ther. 2011;10(2):168–177. doi:https://doi.org/10.1177/1534735410380613
- Li Y, Shi X, Zhang J, Zhang X, Martin RC. Hepatic protection and anticancer activity of curcuma: a potential chemopreventive strategy against hepatocellular carcinoma. Int J Oncol. 2014;44(2):505–513. doi:https://doi.org/10.3892/ijo.2013.2184
- Cheng S-B, Wu L-C, Hsieh Y-C, Wu C-H, Chan Y-J, Chang L-H, Chang C-MJ, Hsu S-L, Teng C-L, Wu C-C. Supercritical carbon dioxide extraction of aromatic turmerone from Curcuma longa Linn. induces apoptosis through reactive oxygen species-triggered intrinsic and extrinsic pathways in human hepatocellular carcinoma HepG2 cells. J Agric Food Chem. 2012;60(38):9620–9630. doi:https://doi.org/10.1021/jf301882b
- Chu Y-L, Ho C-T, Chung J-G, Raghu R, Lo Y-C, Sheen L-Y. Allicin induces anti-human liver cancer cells through the p53 gene modulating apoptosis and autophagy. J Agric Food Chem. 2013;61(41):9839–9848. doi:https://doi.org/10.1021/jf403241s
- Chang H-S, Ko M, Ishizuka M, Fujita S, Yabuki A, Hossain MA, Yamato O. Sodium 2-propenyl thiosulfate derived from garlic induces phase II detoxification enzymes in rat hepatoma H4IIE cells. Nutr Res. 2010;30(6):435–440. doi:https://doi.org/10.1016/j.nutres.2010.06.007
- Belloir C, Singh V, Daurat C, Siess MH, Le Bon AM. Protective effects of garlic sulfur compounds against DNA damage induced by direct- and indirect-acting genotoxic agents in HepG2 cells. Food Chem Toxicol. 2006;44(6):827–834. doi:https://doi.org/10.1016/j.fct.2005.11.005
- De Martino A, Filomeni G, Aquilano K, Ciriolo MR, Rotilio G. Effects of water garlic extracts on cell cycle and viability of HepG2 hepatoma cells. J Nutr Biochem. 2006;17(11):742–749. doi:https://doi.org/10.1016/j.jnutbio.2005.12.005
- Chen C-Y, Liu T-Z, Chen C-H, Wu C-C, Cheng J-T, Yiin S-J, Shih M-K, Wu M-J, Chern C-L. Isoobtusilactone A-induced apoptosis in human hepatoma Hep G2 cells is mediated via increased NADPH oxidase-derived reactive oxygen species (ROS) production and the mitochondria-associated apoptotic mechanisms. Food Chem Toxicol. 2007;45(7):1268–1276. doi:https://doi.org/10.1016/j.fct.2007.01.008
- Lee J, Lee SJ, Lim KT. ZPDC glycoprotein (24 kDa) induces apoptosis and enhances activity of NK cells in N-nitrosodiethylamine-injected Balb/c. Cell Immunol. 2014;289(1-2):1–6. doi:https://doi.org/10.1016/j.cellimm.2014.03.002
- Lizcano L, Siles M, Trepiana J, Hernández M, Navarro R, Ruiz-Larrea M, Ruiz-Sanz J. Piper and vismia species from Colombian Amazonia differentially affect cell proliferation of hepatocarcinoma cells. Nutrients. 2014;7(1):179–195. doi:https://doi.org/10.3390/nu7010179
- Paik SY, Koh KH, Beak SM, Paek SH, Kim JA. The essential oils from Zanthoxylum schinifolium pericarp induce apoptosis of HepG2 human hepatoma cells through increased production of reactive oxygen species. Biol Pharm Bull. 2005;28(5):802–807. doi:https://doi.org/10.1248/bpb.28.802
- Dung TD, Feng C-C, Kuo W-W, Pai P, Chung L-C, Chang S-H, Hsu H-H, Tsai F-J, Lin Y-M, Huang C-Y, et al. Suppression of plasminogen activators and the MMP-2/-9 pathway by a Zanthoxylum avicennae extract to inhibit the HA22T human hepatocellular carcinoma cell migration and invasion effects in vitro and in vivo via phosphatase 2A activation. Biosci Biotechnol Biochem. 2013;77(9):1814–1821. doi:https://doi.org/10.1271/bbb.130060
- Tavakkol-Afshari J, Brook A, Mousavi SH. Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines. Food Chem Toxicol. 2008;46(11):3443–3447. doi:https://doi.org/10.1016/j.fct.2008.08.018
- Jeurissen SM, Punt A, Delatour T, Rietjens IM. Basil extract inhibits the sulfotransferase mediated formation of DNA adducts of the procarcinogen 1′-hydroxyestragole by rat and human liver S9 homogenates and in HepG2 human hepatoma cells. Food Chem Toxicol. 2008;46(6):2296–2302. doi:https://doi.org/10.1016/j.fct.2008.03.010
- Costa S, Utan A, Speroni E, Cervellati R, Piva G, Prandini A, Guerra MC. Carnosic acid from rosemary extracts: a potential chemoprotective agent against aflatoxin B1. An in vitro study. J Appl Toxicol. 2007;27(2):152–159. doi:https://doi.org/10.1002/jat.1186